Kimball Electronics, Inc. (KE) Form 8-K — Nov 4, 2026
Kimball Electronics reported Q1 fiscal 2027 net sales of $390.8 million, up 7% year-over-year with 3% organic growth, driven by a 14% increase in Medical including the Helvoet Polymer Technologies acquisition. Profitability declined sharply: GAAP diluted EPS fell to $0.11 from $0.40, and adjusted diluted EPS dropped to $0.25 from $0.49, pressured by acquisition costs, higher interest expense, and a larger tax provision.
Key figures
- Eps
- 0.11
- Revenue
- 390803000
- Guidance
- Fiscal 2027 net sales at high end of $1,535-$1,560 million range, adjusted operating income 4.4%-4.7% of net sales, capex $50-$60 million
- Net Income
- 2642000
- Total Debt
- 235700000
- Revenue Yoy
- 7%
- Total Assets
- 1237198000
- Cash Position
- 72763000
- Buyback
- $3.1 million for 127,000 shares
- Open orders
- $690 million vs $593 million a year ago
- Adjusted eps
- $0.25 vs $0.49 prior year
- Adjusted ebitda
- $27.6 million vs $26.7 million
- Helvoet net sales
- $12.4 million
- Borrowing capacity
- $198.0 million
- Adjusted net income
- $6.1 million vs $12.3 million
- Cash conversion days
- 82
- Medical sales growth
- 14% (9% organic)
- Organic sales growth
- 3%
- Adjusted operating income
- $17.0 million (4.3% of sales) vs $17.5 million (4.8%)
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.